University of South Carolina

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of South Carolina sits in the top decile of US sponsors by registered trial count (#188 of 15,742 sponsors by registered trial count).

157 total trials 30 currently recruiting 109 completed early-phase tilt top decile by trial count

University of South Carolina: 157 sponsored US clinical trials, 30 recruiting.

University of South Carolina sponsors 157 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 109 completed. 1 of these trials are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

University of South Carolina ranks in the top decile of sponsors by registered trial count (#188 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 85/100

109 of 111 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

157 total, page 4 of 4

COMPLETED NA

Dietary Seaweed and Early Breast Cancer: A Randomized Trial

NCT01663792
COMPLETED NA

Effectiveness of a Church-Based Program at Increasing Physical Activity and Healthy Dietary Habits in African Americans

NCT00379925
COMPLETED NA

Teleconference Group: Breast Cancer in African Americans (STORY)

NCT01339351
COMPLETED Phase 1

The Active by Choice Today (ACT) Trial to Increase Physical Activity

NCT01028144
COMPLETED Phase 1

Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?

NCT01195077
COMPLETED NA

Eating, Activity, and Stress Education

NCT01434004
COMPLETED Phase 1

Brown Seaweed as a Breast Cancer Preventive

NCT01204957
← Previous Page 4 of 4

Phase Distribution

PhaseTrial count
Phase 1 14
Phase 2 6
Phase 3 1

Therapeutic Areas

Obesity 8
Physical Activity 4
Sleep 3
Stroke 3
Overweight and Obesity 3
Socioeconomic Factors 2
Health Status Disparities 2
Child Maltreatment 2
Pediatric Obesity 2
Exercise 2

What is open in the University of South Carolina pipeline

30 recruiting of 157 indexed (19% open); 109 completed (69%).

Phase mix: 1 late (III/IV) vs 20 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of South Carolina: open-pipeline peers nationwide

Peers matched on 157 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 0%5%10%15%20%25% Total trials Recruiting share University of South CarolinaGalderma R&DPfizer's Upjohn has merged with Mylan to form ViatrisAnn & Robert H Lurie Children's Hospital of ChicagoGynecologic Oncology GroupMayo ClinicMemorialCare Health SystemUniversity of North Texas Health Science CenterUniversity of Wisconsin, Milwaukee
University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 157 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of South Carolina page

157 registered trials is a research-attention snapshot, not an endorsement of University of South Carolina or any single study.

  • 30 of University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of South Carolina pipeline card: 157 registered trials from official public datasets.Report a data error.